Soft X-ray tomography of phenotypic switching and the cellular response to antifungal peptoids in Candida albicans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 46, 2009, Pages 19375-19380

  Uchida, Maho ^a   McDermott, Gerry ^a   Wetzler, Modi ^b   Le Gros, Mark A ^c   Myllys, Markko ^a,d   Knoechel, Christian ^a   Barron, Annelise E ^b   Larabell, Carolyn A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTOID; ANTIFUNGAL AGENT;

ARTICLE; CANDIDA ALBICANS; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FUNGUS HYPHAE; IMAGE ANALYSIS; NONHUMAN; NUCLEOLUS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; TOMOGRAPHY; ANTIFUNGAL RESISTANCE; PHENOTYPE; ULTRASTRUCTURE;

CANDIDA; CANDIDA ALBICANS;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; HYPHAE; PEPTOIDS; PHENOTYPE;

EID: 73349123851     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0906145106     Document Type: Article

References (42)

1. Sudbery P, Gow N, Berman J (2004) The distinct morphogenic states of Candida albicans. Trends Microbiol 12:317-324.
2. Ashman RB, et al. (2004) Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol 82:196-204.
3. Monk BC, Goffeau A (2008) Outwitting multidrug resistance to antifungals. Science 321:367-369.
4. Rappleyel CA, Goldman WE (2008) Fungal stealth technology. Trends Immunol 29:18-24.
5. Enoch DA, Ludlam HA, Brown NM (2006) Invasive fungal infections: A review of epidemiology and management options. J Med Microbiol 55:809-818.
6. Richardson M, Lass-Florl C (2008) Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 14:5-24.
7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148:2642-2645.
8. Bullen A (2008) Microscopic imaging techniques for drug discovery. Nat Rev Drug Discov 7:54-67.
9. Hood L, Perlmutter RM (2004) The impact of systems approaches on biological problems in drug discovery. Nat Biotechnol 22:1215-1217.
10. Lang P, Yeow K, Nichols A, Scheer A (2006) Cellular imaging in drug discovery. Nat Rev Drug Discov 5:343-356.
11. Gu WW, Etkin LD, Le Gros MA, Larabell CA (2007) X-ray tomography of Schizosaccharomyces pombe. Differentiation 75:529-535.
12. Larabell CA, Le Gros MA (2004) X-ray tomography generates 3-D reconstructions of the yeast, Saccharomyces cerevisiae, at 60-nm resolution. Mol Biol Cell 15:957-962.
13. Le Gros MA, McDermott G, Larabell CA (2005) X-ray tomography of whole cells. Curr Opin Struct Biol 15:593-600.
14. Parkinson DY, McDermott G, Etkin LD, Le Gros MA, Larabell CA (2008) Quantitative 3-D imaging of eukaryotic cells using soft X-ray tomography. J Struct Biol 162:380-386.
15. Leis A, Rockel B, Andrees L, Baumeister W (2009) Visualizing cells at the nanoscale. Trends Biochem Sci 34:60-70.
16. Le Gros MA, McDermott G, Uchida M, Konechel CG, Larabell CA (2009) High aperture cryogenic light microsocpy. J Microsc 235:1-8.
17. Chao WL, Harteneck BD, Liddle JA, Anderson EH, Attwood DT (2005) Soft X-ray microscopy at a spatial resolution better than 15nm. Nature 435:1210-1213.
18. Attwood DT (1999) Soft X-Rays and Extreme Ultraviolet Radioation: Principles and Applications (Cambridge Univ Press, Cambridge, UK), p 470.
19. Weiss D, et al. (2000) Computed tomography of cryogenic biological specimens based on X-ray microscopic images. Ultramicroscopy 84:185-197.
20. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
21. Bessalle R, Kapitkovsky A, Gorea A, Shalit I, Fridkin M (1990) All-D-magainin: Chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 274:151-155.
22. Latham PW (1999) Therapeutic peptides revisted. Nat Biotechnol 17:755-757.
23. Zuckermann RN, Kerr JM, Kent SBH, Moost WH (1992) Efficient Method for the Preparation of Peptoids [Oligo(N-substituted glycines)] by Submonomer Solid-Phase Synthesis. J Am Chem Soc 114:10646-10647.
24. Miller SM, et al. (1995) Comparison of the Proteolytic Susceptibilities of Homologous L-Amino Acid, D-Amino Acid, and N-Substituted Glycine Peptide and Peptoid Oliogmers. Drug Devel Res 35:20-32.
25. Chongsiriwatana NP, et al. (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci USA 105:2794-2799.
26. Patch JA, Barron AE (2003) Helical Peptoid Mimics of Magainin-2 Amide. J Am Chem Soc 125:12092-12093.
27. Makovitzki A, Avrahami D, Shai Y (2006) Ultrashort antibacterial and antifungal lipopeptides. Proc Natl Acad Sci USA 103:15997-16002.
28. Shai Y (2002) Mode of Action of Membrane Active Antimicrobial Peptides. Biopolymers 66:236-248.
29. Morton CO, et al. (2007) Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived, alpha-helical, cationic peptides on Saccharomyces cerevisiae. Antimicrob Agents Chemother 51:3948-3959.
30. Riquelme M, Roberson RW, McDaniel DP, Bartnicki-Garcia S (2002) The effects of ropy-1 mutation on cytoplasmic organization and intracellular motility in mature hyphae of Neurospora crassa. Fungal Genet Biol 37:171-179.
31. Isola R, Isola M, Conti G, Lantini MS, Riva A (2007) Histatin-induced alterations in Candida albicans: A microscopic and submicroscopic comparison. Microsc Res Tech 70:607-616.
32. Fei W, et al. (2008) Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. J Cell Biol 180:473-482.
33. Szeghalmi A, Kaminskyj S, Gough KM (2007) A synchrotron FTIR microspectroscopy investigation of fungal hyphae grown under optimal and stressed conditions. Anal Bioanal Chem 387:1779-1789.
34. Ceelen H, et al. (1995) Bovine Somatotropin and the Regulatory Process for Veterinary Drug Approval - Open-Letter. Can Vet J 36:595-596.
35. Mayer C, Grummt I (2005) Cellular stress and nucleolar function. Cell Cycle 4:1036-1038.
36. Olson MO, Dundr M (2005) The moving parts of the nucleolus. Histochem Cell Biol 123:203-216.
37. Lo SJ, Lee CC, Lai HJ (2006) The nucleolus: Reviewing oldies to have new understandings. Cell Res 16:530-538.
38. Kremer JR, Mastronarde DN, McIntosh JR (1996) Computer visualization of three-dimensional image data using IMOD. J Struct Biol 116:71-76.
39. Mastronarde DN (1997) Dual-axis tomography: An approach with alignment methods that preserve resolution. J Struct Biol 120:343-352.
40. Erdogan H, Fessler JA (1999) Ordered subsets algorithms for transmission tomography. Phys Med Biol 44:2835-2851.
41. Stayman JW, Fessler JA (2000) Regularization for uniform spatial resolution properties in penalized-likelihood image reconstruction. IEEE Trans Med Imaging 19:601-615.
42. Yushkevich PA, et al. (2006) User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. NeuroImage 31:1116-1128.